(Q40149065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author

Jennifer Rubin Grandis

5

object named as

Jennifer R Grandis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Weiping Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Laura P Stabile

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Phouthone Keohavong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Marjorie Romkes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Anne M Traynor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jill M Siegfried

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thoracic Oncology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

635-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Genetic polymorphisms and lung cancer susceptibility: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

The ErbB/HER receptor protein-tyrosine kinases and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

The ras oncogenes in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Smoking, lung cancers and their TP53 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

The TP53 gene, tobacco exposure, and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

1 reference

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Genetic alterations in primary glioblastomas in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

EGFR gene mutations: a call for global x global views of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

E-cadherin binding modulates EGF receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2930375-0

7 January 2021

10.1016/S1556-0864(15)30375-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409930%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference